zoledronic acid has been researched along with Head and Neck Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billhymer, A; Lundberg, AP; Selting, KA; Tran Hoang, C | 1 |
| Barbai, T; Cserepes, M; Dobos, J; Hegedűs, Z; Kárpáti, A; Kenessey, I; László, V; Nelhűbel, GA; Őrfi, L; Rásó, E; Szabó, B; Szokol, B; Tóvári, J; Türk, D | 1 |
| Draenert, FG; Heymann, PG; Kämmerer, PW; Kretschmer, F; Mandic, R; Neff, A; Saydali, A | 1 |
| Arai, N; Hattori, Y; Inoue, S; Noguchi, M; Takashina, M; Tomihara, K | 1 |
| Inoue, K; Kawada, K; Minami, H; Okabe, K; Sasaki, T; Sawamura, M; Takashima, S; Watanabe, T; Yagi, Y | 1 |
1 trial(s) available for zoledronic acid and Head and Neck Neoplasms
| Article | Year |
|---|---|
A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy.
Topics: Adult; Aged; Breast Neoplasms; Calcium; Diphosphonates; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Hypercalcemia; Imidazoles; Lung Neoplasms; Male; Middle Aged; Multiple Myeloma; Neoplasms; Treatment Outcome; Zoledronic Acid | 2005 |
4 other study(ies) available for zoledronic acid and Head and Neck Neoplasms
| Article | Year |
|---|---|
Combining radiation therapy with zoledronate for the treatment of osteo-invasive feline oral squamous cell carcinoma.
Topics: Animals; Bone Density Conservation Agents; Carcinoma, Squamous Cell; Cat Diseases; Cats; Diphosphonates; Head and Neck Neoplasms; Mouth Neoplasms; Osteolysis; Quality of Life; Squamous Cell Carcinoma of Head and Neck; Zoledronic Acid | 2022 |
EGFR Alterations Influence the Cetuximab Treatment Response and c-MET Tyrosine-Kinase Inhibitor Sensitivity in Experimental Head and Neck Squamous Cell Carcinomas.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Cetuximab; ErbB Receptors; Erlotinib Hydrochloride; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Indoles; Mice; Mice, SCID; Mutation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Squamous Cell Carcinoma of Head and Neck; Sulfonamides; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Zoledronic Acid | 2021 |
Laser-enhanced cytotoxicity of zoledronic acid and cisplatin on primary human fibroblasts and head and neck squamous cell carcinoma cell line UM-SCC-3.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Cells, Cultured; Cisplatin; Coloring Agents; Diphosphonates; Fibroblasts; Head and Neck Neoplasms; Humans; Imidazoles; Indicators and Reagents; Lasers, Semiconductor; Low-Level Light Therapy; Photochemotherapy; Photosensitizing Agents; Tetrazolium Salts; Zoledronic Acid | 2014 |
Extracellular Ca(2+)-dependent enhancement of cytocidal potency of zoledronic acid in human oral cancer cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Calcium; Calcium Chelating Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cytochromes c; Diphosphonates; Dose-Response Relationship, Drug; Head and Neck Neoplasms; Humans; Imidazoles; MCF-7 Cells; Membrane Potential, Mitochondrial; Mitochondria; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck; Zoledronic Acid | 2015 |